دورية أكاديمية
أعرض في EDS

Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach.

التفاصيل البيبلوغرافية
العنوان: Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach.
المؤلفون: Pereira CDS; Laboratory of Functional and Structural Biology, Institute of Biological Sciences, Federal University do Pará, Belém 66075-110, Brazil., Cruz JN; Laboratory of Functional and Structural Biology, Institute of Biological Sciences, Federal University do Pará, Belém 66075-110, Brazil., Ferreira MKM; Laboratory of Functional and Structural Biology, Institute of Biological Sciences, Federal University do Pará, Belém 66075-110, Brazil., Baia-da-Silva DC; Laboratory of Functional and Structural Biology, Institute of Biological Sciences, Federal University do Pará, Belém 66075-110, Brazil., Fontes-Junior EA; Laboratory of Pharmacology of Inflammation and Behavior, Federal University of Pará, Belém 66075-110, Brazil., Lima RR; Laboratory of Functional and Structural Biology, Institute of Biological Sciences, Federal University do Pará, Belém 66075-110, Brazil.
المصدر: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Jul 24; Vol. 16 (7). Date of Electronic Publication: 2023 Jul 24.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, c2004-
مستخلص: Amitriptyline was first introduced as a medication to treat depression. Over time, this substance has been used to treat other conditions, such as gastrointestinal disorders, fibromyalgia, neuropathic pain, and analgesia, among others. However, there are no published studies that provide a broad view of the possible motivations that have led to changes in the use of amitriptyline. In this study, we have identified the landscape of use for amitriptyline based on knowledge mapping of the 100 most-cited articles about this drug. We searched Web of Science Core Collection without time and language restrictions. We obtained 14,446 results, but we only used the 100 most-cited articles that had amitriptyline as the object of study. We collected the following information from each article: authors, country of the corresponding authors, year of publication, citation count, citation density (number of citations per year), and keywords. In addition, we seek to map in the chosen articles study design and research findings. We found that since 1980, the use of amitriptyline has expanded beyond depression, moving to off-label use to treat a variety of diseases and conditions, including post-herpetic neuralgia, neuropathic pain, primary fibrosis, fibromyalgia, and migraine, can be considered a drug with more clinical applicability than its original clinical indication.
References: Mol Pharmacol. 2001 Mar;59(3):427-33. (PMID: 11179435)
Neurology. 2006 Apr 11;66(7):996-1002. (PMID: 16606910)
Pharmacol Ther. 1997;74(3):299-316. (PMID: 9352586)
Mol Psychiatry. 2004 May;9(5):442-73. (PMID: 15037866)
Arch Gen Psychiatry. 1976 Dec;33(12):1479-89. (PMID: 793564)
Med Care. 1992 Jan;30(1):67-76. (PMID: 1729588)
Eur J Neurol. 2009 Sep;16(9):968-81. (PMID: 19708964)
Pain. 1992 May;49(2):205-219. (PMID: 1535121)
Biochemistry. 1997 Jan 14;36(2):370-81. (PMID: 9003190)
J Biol Chem. 1993 Aug 25;268(24):18200-4. (PMID: 8394362)
J Clin Psychiatry. 1990 Dec;51 Suppl B:18-27. (PMID: 2258378)
BMJ. 1995 Feb 18;310(6977):441-5. (PMID: 7873952)
Pain. 1999 Mar;80(1-2):391-8. (PMID: 10204753)
Ann Intern Med. 1990 Feb 15;112(4):293-9. (PMID: 2297206)
Cochrane Database Syst Rev. 2012 Dec 12;12:CD009138. (PMID: 23235671)
Arch Gen Psychiatry. 1975 Nov;32(11):1357-61. (PMID: 1200759)
Eur J Pharmacol. 1969 Sep;7(3):270-7. (PMID: 5351984)
J Clin Psychiatry. 2000;61 Suppl 11:37-41. (PMID: 10926053)
Pharmacoeconomics. 2009;27(2):95-112. (PMID: 19254044)
Am J Med. 2000 Jan;108(1):65-72. (PMID: 11059442)
Neurology. 2012 Apr 24;78(17):1337-45. (PMID: 22529202)
Biomedicines. 2017 May 17;5(2):. (PMID: 28536367)
Am J Epidemiol. 1992 Oct 1;136(7):873-83. (PMID: 1442753)
Pain. 1996 Dec;68(2-3):217-27. (PMID: 9121808)
Nat Med. 2008 Apr;14(4):382-91. (PMID: 18376404)
Endocrinology. 1993 Jul;133(1):312-20. (PMID: 8391426)
Psychosomatics. 2000 Mar-Apr;41(2):104-13. (PMID: 10749947)
Neurology. 1988 Sep;38(9):1427-32. (PMID: 3412591)
Cell Mol Neurobiol. 1999 Aug;19(4):467-89. (PMID: 10379421)
Neuropharmacology. 1971 Sep;10(5):521-36. (PMID: 4399540)
Ann Neurol. 2006 Apr;59(4):652-61. (PMID: 16450381)
Arch Intern Med. 1999 Sep 13;159(16):1931-7. (PMID: 10493324)
Mol Pharmacol. 1971 Jan;7(1):66-80. (PMID: 5552252)
Int J Mol Sci. 2017 Nov 21;18(11):. (PMID: 29160850)
Arch Bronconeumol. 2011 Apr;47(4):213. (PMID: 21281995)
Arch Gen Psychiatry. 1975 Jan;32(1):17-21. (PMID: 1089399)
J Affect Disord. 2000 Apr;58(1):19-36. (PMID: 10760555)
J Physiol. 1968 Apr;195(3):715-29. (PMID: 5649642)
Life Sci. 2000 Nov 24;68(1):29-39. (PMID: 11132243)
JAMA. 2004 Jul 21;292(3):338-43. (PMID: 15265848)
J Clin Epidemiol. 2006 Jan;59(1):7-10. (PMID: 16360555)
Br J Pharmacol. 2007 Jul;151(6):737-48. (PMID: 17471183)
CNS Drug Rev. 2001 Fall;7(3):249-64. (PMID: 11607047)
Pharmacol Biochem Behav. 1982 Mar;16(3):449-54. (PMID: 7200610)
Scientometrics. 2010 Aug;84(2):523-538. (PMID: 20585380)
FASEB J. 2008 Feb;22(2):338-42. (PMID: 17884971)
Lancet. 2016 Aug 27;388(10047):881-90. (PMID: 27289172)
Arch Gen Psychiatry. 1977 Feb;34(2):236-9. (PMID: 14603)
ACS Chem Neurosci. 2023 Apr 5;14(7):1261-1277. (PMID: 36930958)
Ann Rheum Dis. 2008 Apr;67(4):536-41. (PMID: 17644548)
JAMA. 2001 May 2;285(17):2208-15. (PMID: 11325322)
Psychopharmacology (Berl). 1987;93(2):193-200. (PMID: 2962217)
J Pharm Technol. 2023 Feb;39(1):35-40. (PMID: 36755751)
Ann Rheum Dis. 2017 Feb;76(2):318-328. (PMID: 27377815)
Acta Neuropsychiatr. 2018 Dec;30(6):307-322. (PMID: 29388517)
J Clin Pharmacol. 2001 Nov;41(11):1149-79. (PMID: 11697750)
Psychopharmacology (Berl). 1985;85(3):367-70. (PMID: 3923523)
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142. (PMID: 31643080)
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Oct 20;843(1):100-13. (PMID: 16798119)
Am J Health Syst Pharm. 2004 Jan 15;61(2):160-73; quiz 175-6. (PMID: 14750401)
Cephalalgia. 2000 Jun;20(5):486-508. (PMID: 11037746)
Neurology. 2002 Aug 27;59(4):490-8. (PMID: 12196640)
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Aug 25;794(1):35-47. (PMID: 12888196)
ACS Chem Neurosci. 2021 Feb 3;12(3):354-362. (PMID: 33438398)
Biochem Pharmacol. 1975 Apr 15;24(8):847-52. (PMID: 1125084)
J Pharmacol Exp Ther. 1998 Jan;284(1):208-14. (PMID: 9435180)
Mov Disord. 2011 Oct;26 Suppl 3:S42-80. (PMID: 22021174)
Neurology. 1987 Apr;37(4):589-96. (PMID: 2436092)
Clin Pharmacol Ther. 2013 May;93(5):402-8. (PMID: 23486447)
J Clin Oncol. 2014 Jun 20;32(18):1941-67. (PMID: 24733808)
Pain. 1989 Jan;36(1):27-36. (PMID: 2465530)
Drugs. 2005;65(9):1239-82. (PMID: 15916450)
Psychopharmacology (Berl). 1988;95(3):298-302. (PMID: 3137614)
N Engl J Med. 2005 Oct 27;353(17):1819-34. (PMID: 16251538)
N Engl J Med. 1996 Jul 4;335(1):32-42. (PMID: 8637540)
Arch Gen Psychiatry. 1983 Dec;40(12):1327-34. (PMID: 6418109)
Am J Psychiatry. 1974 Feb;131(2):186-91. (PMID: 4587807)
Arthritis Rheum. 1996 Nov;39(11):1852-9. (PMID: 8912507)
Pharmacol Rev. 2006 Sep;58(3):521-90. (PMID: 16968950)
J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1372-3. (PMID: 20543189)
J Am Geriatr Soc. 2008 Jul;56(7):1333-41. (PMID: 18510583)
Neurology. 2011 May 17;76(20):1758-65. (PMID: 21482920)
Eur J Pharmacol. 1969 Mar;5(4):357-66. (PMID: 5786359)
Biomed Digit Libr. 2006 Jun 29;3:7. (PMID: 16805916)
BMJ. 2006 Feb 18;332(7538):391-7. (PMID: 16452103)
Int J Pharm. 2005 Jul 14;298(1):198-205. (PMID: 15951143)
Eur J Pharmacol. 1969 Mar;5(4):367-73. (PMID: 5786360)
Neuropsychopharmacology. 2000 Apr;22(4):370-9. (PMID: 10700656)
N Engl J Med. 1992 May 7;326(19):1250-6. (PMID: 1560801)
J Clin Psychopharmacol. 1986 Dec;6(6):339-42. (PMID: 3805326)
Gut. 1999 Sep;45 Suppl 2:II60-8. (PMID: 10457047)
Neurosci Lett. 2002 Aug 9;328(2):129-32. (PMID: 12133572)
Arch Gen Psychiatry. 1990 Mar;47(3):259-66. (PMID: 2407208)
Arch Intern Med. 2006 May 8;166(9):1021-6. (PMID: 16682577)
Lancet. 1972 Jun 17;1(7764):1297-300. (PMID: 4113396)
Ethn Dis. 2002 Winter;12(1):S28-30. (PMID: 11913654)
Arch Gen Psychiatry. 1974 May;30(5):667-74. (PMID: 4824200)
Pain. 2001 Nov;94(2):215-224. (PMID: 11690735)
Front Pharmacol. 2022 Sep 06;13:973118. (PMID: 36147324)
Arthritis Rheum. 1986 Nov;29(11):1371-7. (PMID: 3535811)
N Engl J Med. 1998 Sep 24;339(13):875-82. (PMID: 9744971)
Arch Gen Psychiatry. 1999 Sep;56(9):829-35. (PMID: 12884889)
Clin Pharmacokinet. 1984 Jan-Feb;9(1):1-25. (PMID: 6362950)
Focus (Am Psychiatr Publ). 2018 Oct;16(4):420-429. (PMID: 32021580)
J Affect Disord. 1988 Jan-Feb;14(1):83-95. (PMID: 2963054)
Drugs. 1986 Dec;32(6):481-508. (PMID: 2878798)
J Clin Endocrinol Metab. 1987 Jul;65(1):141-52. (PMID: 3034952)
Curr Pharm Des. 2004;10(20):2463-75. (PMID: 15320756)
Gut. 2009 Mar;58(3):367-78. (PMID: 19001059)
Eur J Cancer. 2008 Jul;44(11):1507-15. (PMID: 18571399)
J Clin Psychiatry. 2010 Oct;71(10):1259-72. (PMID: 21062615)
Neurology. 1982 Jun;32(6):671-3. (PMID: 6283422)
Int J Eat Disord. 2007 May;40(4):310-20. (PMID: 17370290)
Nature. 1977 Sep 8;269(5624):163-5. (PMID: 20581)
فهرسة مساهمة: Keywords: amitriptyline; bibliometric analysis; scientometrics; therapeutic effect
تواريخ الأحداث: Date Created: 20230729 Latest Revision: 20230801
رمز التحديث: 20230801
مُعرف محوري في PubMed: PMC10386017
DOI: 10.3390/ph16071047
PMID: 37513958
قاعدة البيانات: MEDLINE
الوصف
تدمد:1424-8247
DOI:10.3390/ph16071047